Corrigendum to 'MUC1-C Is a Common Driver of Acquired Osimertinib Resistance in NSCLC' [Journal of Thoracic Oncology 19 Issue 3 (2024) 434-450].
Haratake N, Ozawa H, Morimoto Y, Yamashita N, Daimon T, Bhattacharya A, Wang K, Nakashoji A, Isozaki H, Shimokawa M, Kikutake C, Suyama M, Hashinokuchi A, Takada K, Takenaka T, Yoshizumi T, Mitsudomi T, Hata AN, Kufe D.
Haratake N, et al. Among authors: hata an.
J Thorac Oncol. 2024 Dec 18:S1556-0864(24)02499-7. doi: 10.1016/j.jtho.2024.12.004. Online ahead of print.
J Thorac Oncol. 2024.
PMID: 39692639
Free article.
No abstract available.